The new insights of hyperbaric oxygen therapy: focus on inflammatory bowel disease

Leilei Chen,Yan Wang,Huihui Zhou,Yi Liang,Fengqin Zhu,Guangxi Zhou

DOI: https://doi.org/10.1093/pcmedi/pbae001

2024-01-08

Precision Clinical Medicine

Abstract:Abstract Inflammatory bowel diseases (IBD), with an increasing incidence, pose a significant health burden. Although there have been significant advances in the treatment of IBD, more progress is still needed. Hyperbaric oxygen therapy (HBOT) has been shown to treat a host of conditions such as carbon monoxide poisoning, decompression sickness, and gas gangrene. In the last few years, there has been an increase in research into the use of HBOT as an adjunct to conventional treatment for IBD. Related research has shown that HBOT may exert its therapeutic effects by decreasing oxidative stress, inhibiting mucosal inflammation, promoting ulcer healing, influencing gut microbes, and reducing the incidence of IBD complications. This paper aims to provide a comprehensive review of experimental and clinical trials exploring HBOT as a supplement to IBD treatment strategies.

medicine, research & experimental

What problem does this paper attempt to address?

The paper attempts to address the role and potential mechanisms of hyperbaric oxygen therapy (HBOT) in the treatment of inflammatory bowel disease (IBD). Specifically, the paper aims to synthesize the results of experimental and clinical trials to explore the efficacy and safety of HBOT as an adjunctive treatment for IBD. The key areas of focus in the study include:

1. **Reducing oxidative stress**: By increasing the levels of antioxidant enzymes (such as superoxide dismutase SOD and glutathione peroxidase GSH-Px), reducing the production of reactive oxygen species (ROS), thereby alleviating tissue damage.
2. **Inhibiting inflammatory response**: Reducing the expression of pro-inflammatory cytokines (such as IL-1, IL-6, TNF-α, etc.) while promoting the production of anti-inflammatory cytokines (such as IL-10), improving intestinal inflammation.
3. **Protecting and repairing the intestinal epithelial barrier**: By upregulating the expression of mucin MUC2 and promoting the expression of tight junction proteins, protecting the function of the intestinal mucosal barrier.
4. **Promoting stem cell differentiation and repair cell recruitment**: Enhancing the proliferation and differentiation ability of stem cells, promoting the repair of damaged tissues.
5. **Increasing blood supply to the wound site**: By promoting angiogenesis, improving blood supply to ischemic areas, thereby accelerating wound healing.

In summary, the paper aims to comprehensively evaluate the potential role of hyperbaric oxygen therapy in the treatment of inflammatory bowel disease and propose its prospects as a complementary treatment method.